Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community
-
Plus Therapeutics Introduces REYOBIQ™, FDA-Accepted Proprietary Name for Lead Drug Candidate
-
Quantum BioPharma Continues to Grow Its Crypto Assets and Diversify Its Treasury With the Purchase of Another USD $1,500,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies
-
Highwire Achieves Double-Digit Growth in 2024, Elevates Michael Byrnes to Chief Growth Officer
-
Nayax Introduces Innovative State-of-Charge Feature for EV Kiosk, Elevating EV Charging Experience
-
InflaRx Reports Full Year 2024 Results and Highlights Key Achievements and Expected Milestones
-
3 E Network Technology Group Limited Announces Strategic Equity Investment in HashBeaver to Accelerate Blockchain Innovation
-
Quantum BioPharma Continues to Grow Its Crypto Assets and Diversify Its Treasury With the Purchase of Another USD $1,500,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies
-
Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans
-
XOMA Royalty Declares Quarterly Preferred Stock Dividends
-
Nykredit Realkredit A/S – annual general meeting 2025
-
Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments
-
Chris Miller, Former Acting U.S. Secretary of Defense Appointed by President Trump, Joins the Draganfly Board of Directors
-
Emerging Markets Report: Ceilings & Floors
-
Emerging Markets Report: Ceilings & Floors
-
Clearside Biomedical’s Lead Clinical Program CLS-AX in Wet AMD and Suprachoroidal Delivery Platform Highlighted at the 2025 Wet AMD & Diabetic Eye Disease Summit
-
British King Gold Project: Filing of NI43-101 Technical Report
-
MEXC Introduces Bedrock (BR) Listing with Spot & Futures Trading, Offering 150,000 USDT to Power Next-Gen DeFi Restaking
-
MEXC Introduces Bedrock (BR) Listing with Spot & Futures Trading, Offering 150,000 USDT to Power Next-Gen DeFi Restaking
-
Cognition Therapeutics Reports Year End 2024 Financial Results and Provides Business Update
-
Monte Rosa Therapeutics Announces Fourth Quarter 2024 Financial Results and Provides Corporate Update Including New Clinical Results from MRT-6160 and MRT-2359 Programs
-
Plymouth Industrial REIT Expands Portfolio in Atlanta and Cincinnati
-
First Helium Announces Shallow Heavy Oil Discovery
-
Wugen Announces Dosing of First Patients in Pivotal Trial of Off-the-Shelf, Allogeneic, CD7-Targeted CAR-T Cell Therapy WU-CART-007
-
Koelis Announces Innovative Products at EAU 2025 enhancing MRI Fusion Biopsy Workflows and promoting Focal Therapy in Prostate Cancer
-
Sharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on March 28, 2025
-
RYVYL Secures Major Payments-as-a-Service Contracts, Set to Onboard Nearly One Million New Accounts in the next 12 Months
-
KFC easily remains the fried chicken champion in showdown with AI
-
Enthusiast Gaming’s Addicting Games Partners with ByteBrew to Provide Enhanced Analytics for its Web Game Developers
-
Plug CEO, Andy Marsh, Reinforces Commitment to Company Mission by Taking 50% of Compensation in PLUG Stock for 2025
-
ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
-
Destination XL Group, Inc. Reports Fiscal 2024 Fourth Quarter and Full-Year Financial Results
-
Autolus Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
-
Introducing FUJIFILM GFX100RF: The first FUJIFILM GFX System Fixed-Lens Mirrorless Digital Camera
-
Immuneering Names Dr. Igor Matushansky as Chief Medical Officer
-
Paramount Secures Approval from Oregon State Agencies for Proposed Technologies and Processes at Its Wholly Owned Grassy Mountain Gold Project
-
Sionna Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
-
Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries
-
Baker Hughes to Provide Fully Integrated Completions for Petrobras’ Offshore Fields
-
Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq
-
Avalo Reports 2024 Financial Results and Recent Business Updates
-
SweetWater Brewing Company and Georgia Aquarium Celebrate Third Year of Partnership with Limited Edition Aquarium-Themed Can Art for OG IPA
-
Intermap’s Insurance Business Starts 2025 With Strong Growth
-
OTC Markets Group Welcomes QNB Corp. to OTCQX
-
Axonius Unveils the Axonius Asset Cloud, a Suite of Products that Transforms Asset Intelligence into Intelligent Action
-
Sanoma Corporation - Managers' Transactions
-
Sitryx initiates Phase 1 clinical trial of potential disease-modifying treatment for atopic dermatitis SYX-5219
-
Amphista Therapeutics to present novel mechanism of action for the degradation of BRD9 using its proprietary Targeted Glue® technology at two key upcoming scientific conferences
-
Dimensional Fund Advisors Ltd. : Form 8.3 - JOHN WOOD GROUP PLC - Ordinary Shares
-
ExoraPad Innovation brings life to AI Vetting
